Sippican Capital Advisors Pfizer Inc Transaction History

Sippican Capital Advisors

$126 Million
Q4 2024

A detailed history of Sippican Capital Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Sippican Capital Advisors holds 41,397 shares of PFE stock, worth $1.1 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

41,397

Previous 88,326 53.13%

Holding current value

$1.1 Million

Previous $2.56 Million 57.04%

% of portfolio

0.87%

Previous 1.96%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$24.8 - $30.19 $1.16 Million - $1.42 Million	-46,929 Reduced 53.13%	41,397 $1.1 Million
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $747 - $847	27 Added 0.03%	88,326 $2.56 Million
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $139,864 - $163,895	5,537 Added 6.69%	88,299 $2.47 Million
Q1 2024 May 02, 2024	BUY	$25.89 - $29.73 $378,460 - $434,593	14,618 Added 21.45%	82,762 $2.3 Million
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $487,507 - $633,218	18,657 Added 37.7%	68,144 $1.96 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $156,374 - $182,786	4,873 Added 10.92%	49,487 $1.64 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $10,113 - $11,701	-280 Reduced 0.62%	44,614 $1.64 Million
Q1 2023 Jul 14, 2023	BUY	$39.39 - $51.28 $23,121 - $30,101	587 Added 1.32%	44,894 $1.83 Million
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $10,646 - $13,897	-255 Reduced 0.57%	44,307 $0
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $3,282 - $4,006	-75 Reduced 0.17%	44,562 $1.95 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $11,585 - $13,737	-249 Reduced 0.55%	44,637 $2.34 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $40,168 - $49,773	-878 Reduced 1.92%	44,886 $2.32 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $99,581 - $147,612	-2,410 Reduced 5.0%	45,764 $2.7 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $60,248 - $77,394	-1,535 Reduced 3.09%	48,174 $2.07 Million
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $27,183 - $30,794	-757 Reduced 1.5%	49,709 $1.95 Million
Q1 2021 Apr 15, 2021	BUY	$33.49 - $37.77 $226,425 - $255,362	6,761 Added 15.47%	50,466 $1.83 Million
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $55,459 - $70,521	-1,657 Reduced 3.65%	43,705 $1.61 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $35,337 - $41,459	1,113 Added 2.52%	45,362 $1.67 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $52,378 - $63,543	-1,739 Reduced 3.78%	44,249 $1.45 Million
Q1 2020 Apr 16, 2020	BUY	$27.03 - $38.62 $16,109 - $23,017	596 Added 1.31%	45,988 $1.5 Million
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $65 - $74	-2 Reduced -0.0%	45,392 $1.78 Million
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $7,310 - $9,479	-225 Reduced 0.49%	45,394 $1.63 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $43,451 - $48,786	-1,175 Reduced 2.51%	45,619 $1.98 Million
Q1 2019 Apr 17, 2019	SELL	$37.5 - $41.2 $21,487 - $23,607	-573 Reduced 1.21%	46,794 $1.99 Million
Q4 2018 Jan 16, 2019	BUY	$38.47 - $43.86 $30,776 - $35,088	800 Added 1.72%	47,367 $2.07 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $146,738 - $177,985	-4,257 Reduced 8.38%	46,567 $2.04 Million
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $89,045 - $94,931	2,700 Added 5.61%	50,824 $1.84 Million
Q1 2018 Apr 24, 2018	BUY	$31.91 - $37.02 $3,191 - $3,702	100 Added 0.21%	48,124 $1.71 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $4,989 - $5,293	150 Added 0.31%	48,024 $1.74 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $1.48 Million - $1.63 Million	47,874	47,874 $1.71 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Account

Sippican Capital Advisors Pfizer Inc Transaction History